Probability of immune recovery (time from cART start to CD4+ count gain ≥200 cells/mmc) by Kaplan Meier estimates.

<p>Kaplan Meier estimates of the probability of achieving CD4+ T-cells count ≥200 cells/mmc from cART start according to Recent and non Recent HIV Infection; log rank test. The continuous line represents Less Recent HIV Infections (NRHI), the dot line represents Recent HIV Infections (RHI).</p

Proportion of Recent HIV Infections by calendar period of enrolment.

<p>The graph illustrates the proportion of Recent HIV Infections (RHI), defined as a positive HIV serological test within 12 months since the last negative one, according to calendar period of seroconversion (1996–2000, 2001–2006, 2007–2009, 2010–2014). X-axis: calendar periods, Y-axis: proportion of RHI in percentages.</p

Parameters associated with Recent HIV Infections (RHI) by univariate and multivariate logistic regression analysis.

<p>Parameters associated with Recent HIV Infections (RHI) by univariate and multivariate logistic regression analysis.</p

Proportion of patients achieving a HIV-RNA ≤500 copies/mL at 6 months from the date of starting cART.

<p>Proportion of patients achieving a HIV-RNA ≤500 copies/mL at 6 months from the date of starting cART.</p

Characteristics of the study population according to RHI status.

<p>Characteristics of the study population according to RHI status.</p

Characteristics of patients with a known date of seroconversion according to calendar period.

<p>Characteristics of patients with a known date of seroconversion according to calendar period.</p

Other factors associated with the chance of starting ART - Relative hazards (RH) from fitting a Cox regression.

<p>Other factors associated with the chance of starting ART - Relative hazards (RH) from fitting a Cox regression.</p

Phylogenetic tree of HIV-1 C2V5 nucleotide clonal sequences of subject #53 during DAA therapy.

<p>The viral sequences at the various time points are indicated by different colours, see table insert. Bootstrap values ≥80% are indicated. Bars indicate p distance scale. In the insert mean diversity (number of nucleotide substitutions/site) of the sequences detected at different time points is reported.</p

Kaplan-Meier estimates of the cumulative proportion of patients starting ART by 30 days from ADE diagnosis, according to period of starting ART (a) and group of ADEs (b).

<p>Kaplan-Meier estimates of the cumulative proportion of patients starting ART by 30 days from ADE diagnosis, according to period of starting ART (a) and group of ADEs (b).</p

Flow diagram showing the original population of people diagnosed with AIDS while ART-naive, patients definitively considered for the analysis, and reasons for exclusion.

<p>Flow diagram showing the original population of people diagnosed with AIDS while ART-naive, patients definitively considered for the analysis, and reasons for exclusion.</p